tradingkey.logo

Abbott falls after Q4 revenue misses estimates, downbeat Q1 profit forecast

ReutersJan 22, 2026 2:38 PM

Shares of medical device maker Abbott Laboratories ABT.N fall 10.5% to $107.43

Co posts Q4 revenue of $11.46 billion, missing analysts' estimate of $11.8 billion, according to data compiled by LSEG

*ABT expects adjusted per-share profit of between $1.12 and $1.18 for the first quarter, below analysts' estimate of $1.20 per share

Forecasts 2026 adj. profit in the range of $5.55 to $5.80 per share, compared with analysts' estimate of $5.68 per share

*"I continue to think this story is challenged, and now investors will have many more questions as to the timing and strategic rationale of the EXAS acquisition, which we never thought made a whole lot of sense," said Bernstein analyst Christian Moore

Reports Q4 adj. profit of $1.50 per share, in line with estimates

ABT stock climbed 10.7% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI